Central Admixture Pharmacy Services, Inc. recalls HyperLyte CR Injection, 250 mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18
Recalled May 31, 2023 · FDA recall D-0755-2023 · Central Admixture Pharmacy Services
Hazard
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile. · FDA Class II
Units
1673 bags
Sold at
Nationwide in the USA.
Description
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Product
HyperLyte CR Injection, 250 mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8094-2, code 7128580942.
Manufacturer(s)
Central Admixture Pharmacy Services, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →